BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33245986)

  • 1. Clinicopathological features and prognostic analysis of 247 small cell lung cancer with limited-stage after surgery.
    Liu L; Wei J; Teng F; Zhu Y; Xing P; Zhang J; Guo Y; Dong J; Ying J; Li J; Yang L
    Hum Pathol; 2021 Feb; 108():84-92. PubMed ID: 33245986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical Expression of Immune Checkpoints; CTLA-4, LAG3, and TIM-3 in Cancer Cells and Tumor-infiltrating Lymphocytes (TILs) in Colorectal Carcinoma.
    Abdelrahman DI; Elhasadi I; Anbaig A; Bakry A; Mandour D; Wasefy T; Yehia AM; Alorini M; Shalaby AM; Yahia AIO; Alabiad MA
    Appl Immunohistochem Mol Morphol; 2024 Feb; 32(2):71-83. PubMed ID: 38108390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [CD45RO⁺ Memory T Lymphocytes As A Candidate Marker for Non-small Cell Lung Cancer].
    Tan Q; Li H; Yu M; Tang X; Tan J; Zhang S; Wang J
    Zhongguo Fei Ai Za Zhi; 2021 Apr; 24(4):254-264. PubMed ID: 33910273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of spread through air spaces in small cell lung cancer.
    Han L; Huang Z; Zhang J; Chen Y; Wang J; Xiong Y; Yao W; Hou L; Zhang L; Yu H; Song N; Zhang Z; Zhu Y
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):5301-5308. PubMed ID: 36416957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological correlation of PD-L1 and TET1 expression with tumor-infiltrating lymphocytes in non-small cell lung cancer.
    Ahn H; Lee HJ; Lee JH; Cho HD; Oh MH; Son JW; Jang SH
    Pathol Res Pract; 2020 Nov; 216(11):153188. PubMed ID: 32919305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of PD-L1 expression and CD8+ T cell infiltration in pulmonary neuroendocrine tumors.
    Wang H; Li Z; Dong B; Sun W; Yang X; Liu R; Zhou L; Huang X; Jia L; Lin D
    Diagn Pathol; 2018 May; 13(1):30. PubMed ID: 29789013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [First-line chemotherapy and its survival analysis of 394 patients with extensive-stage small cell lung cancer in a single institute].
    Ma M; Wang M; Xu Y; Hu K; Liu H; Li L; Zhong W; Zhang L; Zhao J; Wang H
    Zhongguo Fei Ai Za Zhi; 2014 Jan; 17(1):8-14. PubMed ID: 24398308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of CD45RO+ tumor-infiltrating lymphocytes in post-operative survival of breast cancer patients.
    Ahmadvand S; Faghih Z; Montazer M; Safaei A; Mokhtari M; Jafari P; Talei AR; Tahmasebi S; Ghaderi A
    Cell Oncol (Dordr); 2019 Jun; 42(3):343-356. PubMed ID: 30825183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PD-1 and PD-L1 expression in HNSCC primary cancer and related lymph node metastasis - impact on clinical outcome.
    Schneider S; Kadletz L; Wiebringhaus R; Kenner L; Selzer E; Füreder T; Rajky O; Berghoff AS; Preusser M; Heiduschka G
    Histopathology; 2018 Oct; 73(4):573-584. PubMed ID: 29742291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor infiltrating lymphocytes and PD-L1 expression in brain metastases of small cell lung cancer (SCLC).
    Berghoff AS; Ricken G; Wilhelm D; Rajky O; Widhalm G; Dieckmann K; Birner P; Bartsch R; Preusser M
    J Neurooncol; 2016 Oct; 130(1):19-29. PubMed ID: 27436101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of tumor-infiltrating lymphocytes in non-small cell lung cancer patients who received neoadjuvant chemotherapy followed by surgery.
    Hou Z; Zhao L; Zou L; Li B
    Adv Clin Exp Med; 2023 Aug; 32(8):847-853. PubMed ID: 36881364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor size and lymph node metastasis are prognostic markers of small cell lung cancer in a Chinese population.
    Wang L; Dou X; Liu T; Lu W; Ma Y; Yang Y
    Medicine (Baltimore); 2018 Aug; 97(31):e11712. PubMed ID: 30075575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical Resection of SCLC: Prognostic Factors and the Tumor Microenvironment.
    Zhao X; Kallakury B; Chahine JJ; Hartmann D; Zhang Y; Chen Y; Zhang H; Zhang B; Wang C; Giaccone G
    J Thorac Oncol; 2019 May; 14(5):914-923. PubMed ID: 30735815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors for lymph node negative stage I and IIA non-small cell lung cancer: multicenter experiences.
    Oven Ustaalioglu BB; Unal OU; Turan N; Bilici A; Kaya S; Eren T; Ulas A; Inal A; Berk V; Demirci U; Alici S; Bal O; Benekli M; Gumus M
    Asian Pac J Cancer Prev; 2013; 14(11):6287-92. PubMed ID: 24377519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of tumor-infiltrating lymphocytes investigated using routine H&E slides in small cell lung cancer.
    Zhou G; Zheng J; Chen Z; Hu D; Li S; Zhuang W; He Z; Lin G; Wu B; Zhang W; Fang W; Zheng F; Wang J; Chen G; Chen M
    Radiat Oncol; 2022 Jul; 17(1):127. PubMed ID: 35850908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The differences of biological behavior based on the clinicopathological data between resectable large-cell neuroendocrine carcinoma and small-cell lung carcinoma.
    Kinoshita T; Yoshida J; Ishii G; Aokage K; Hishida T; Nagai K
    Clin Lung Cancer; 2013 Sep; 14(5):535-40. PubMed ID: 23792008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor infiltrative growth pattern correlates with the immune microenvironment and is an independent factor for lymph node metastasis and prognosis in stage T1 esophageal squamous cell carcinoma.
    Zhao Y; Xu E; Yang X; Zhang Y; Chen H; Wang Y; Jin M
    Virchows Arch; 2020 Sep; 477(3):401-408. PubMed ID: 32232560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-infiltrating lymphocytes are significantly associated with better overall survival and disease-free survival in triple-negative but not estrogen receptor-positive breast cancers.
    Krishnamurti U; Wetherilt CS; Yang J; Peng L; Li X
    Hum Pathol; 2017 Jun; 64():7-12. PubMed ID: 28153508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroendocrine marker staining pattern categorization of small-sized pulmonary large cell neuroendocrine carcinoma.
    Minami K; Tanaka Y; Ogawa H; Jimbo N; Nishio W; Yoshimura M; Itoh T; Maniwa Y
    Thorac Cancer; 2019 Nov; 10(11):2152-2160. PubMed ID: 31583856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Prognostic Value of Sex-Determining Region Y-Box 2 and CD8+ Tumor-Infiltrating Lymphocytes in Limited-Stage Small-Cell Lung Cancer.
    Lee J; Jung YY; Lee JH; Hong M; Hwang HW; Hong SA; Hong SH
    Oncology; 2021; 99(8):528-538. PubMed ID: 34107469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.